Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend | RobinsPost News & Noticias

People 50 and older should get pneumococcal vaccine, CDC recommends


U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ... Read More

Six vaccines that can keep you safe this holiday season


Stay healthy this holiday season by getting vaccinated against COVID-19, flu, RSV, and other viruses. Consult a healthcare professional for guidance. Read More

How to Get the Vaccines You Need Now


Learn how to get the vaccines you need now to protect yourself from illnesses, including flu, RSV, measles, Covid-19, and others ... Read More

Pfizer’s Latest Study on 20-Valent Pneumococcal Vaccine: What Investors Need to Know


Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ... Read More

As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start


With vaccine sales on the decline across the industry, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. But in the third quarter, the company recorded encouraging sales ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus